Tánaiste warns Trump’s pharma tariffs could raise drug prices and hurt global supply

Tánaiste Simon Harris urges US-EU cooperation on pharma trade and calls for review of EU-Israel agreement amid Gaza crisis
Tánaiste warns Trump’s pharma tariffs could raise drug prices and hurt global supply

Simon Harris also reiterated his call for a review of the EU-Israel Association Agreement in response to Israel's escalating onslaught in Gaza.

The Trump administration has a "fundamental misunderstanding" of how the pharmaceutical sector works in terms of trade, Tánaiste Simon Harris has said.

The Tánaiste said pharma companies choose to locate in Ireland because they want access to 460 million consumers, and that for the US to make moves that would shrink the global reach of companies does not make any economic or financial sense.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

CONNECT WITH US TODAY

Be the first to know the latest news and updates

More in this section

Politics

Newsletter

From the corridors of power to your inbox ... sign up for your essential weekly political briefing.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited